Spinal Muscular atrophy overview

Jump to navigation Jump to search

Spinal Muscular Atrophy Microchapters

Home

Patient Info

Overview

Epidemiology and Demographics

Risk Factors

Screening

Other forms

Molecular Biology

Genetics

Types

Diagnosis

Diagnosis

Full Differential Diagnosis

Symptom

Physical Examination

Electrolyte & Biomarker Studies

Electrocardiogram

Chest X Ray

MRI and CT

Echocardiography or Ultrasound

Other Imaging Findings

Pathology

Other Diagnostic Studies

Treatment

Outcome measures

Therapeutics development

Indications For Surgery

Research

Pre-Operative Assessment

Post-Operative Assessment

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Spinal Muscular atrophy overview Resources

Most recent articles on Spinal Muscular atrophy overview

Most cited articles on Spinal Muscular atrophy overview

Review articles on Spinal Muscular atrophy overview

Review articles on Spinal Muscular atrophy overview

CME Programs on Spinal Muscular atrophy overview

Powerpoint slides on Spinal Muscular atrophy overview

Images of Spinal Muscular atrophy overview

Ongoing Trials on Spinal Muscular atrophy overview at Clinical Trials.gov

US National Guidelines Clearinghouse on Spinal Muscular atrophy overview

NICE Guidance on Spinal Muscular atrophy overview

FDA on Spinal Muscular atrophy overview

CDC on Spinal Muscular atrophy overview

Spinal Muscular atrophy overview in the news

Blogs on Spinal Muscular atrophy overview

Directions to Hospitals Treating Spinal Muscular atrophy overview

Risk calculators and risk factors for Spinal Muscular atrophy overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.


Spinal muscular atrophy is the commonest genetic cause of infant mortality. It is an autosomal recessive neuromuscular disorder caused by loss of survival motor neuron gene (SMN1). It is primarily a pediatrics disorder resulting from degeneration of anterior horn cells (lower motor neurons) in spinal cord and brain stem nuclei. It is characterized by progressive muscle weakness predominantly affecting the proximal muscles. Though the disease is still considered to be incurable, recent advancements in the field of molecular genetic have helped in understanding the pathogenesis and raises hope for a cure in future.

References

Template:WH Template:WS